Document is current
Any future updates will be listed below
-
Authors
Carreira, Mariana
Barros, Leandro
Cruz, Rafael M
Ferreira, Cristina
Costa, Carla
Ferreira, Carlos M
Mensurado, Sofia
Silva-Santos, Bruno https://orcid.org/0000-0003-4141-9302
Blanco-Domínguez, Rafael https://orcid.org/0000-0003-2448-8699
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04777994 at ClinicalTrials.govDocuments that mention this clinical trial
CXCR3 signaling promotes Delta One T cell recruitment and antitumor efficacy in colorectal cancer
https://doi.org/10.1136/jitc-2025-014668
1403-A PTPN2/N1 inhibitor ABBV-CLS-484 unleashes potent anti-tumor immunity
https://doi.org/10.1136/jitc-2023-sitc2023.1403-a
311 Inhibition of PTPN2/N1 by the small molecule inhibitor ABBV-CLS-484 enhances the efficacy of adoptive T cell therapy
https://doi.org/10.1136/jitc-2025-sitc2025.0311
-
Funding
Funding for this research was provided by:
Fundação para a Ciência e a Tecnologia (2021.01953.CEECIND)
Fundação para a Ciência e a Tecnologia (2023.14157.PEX)
Fundação para a Ciência e a Tecnologia (PTDC/MED-ONC/6829/2020)
Takeda Development Center Americas, Inc (N/A)
Liga Portuguesa Contra o Cancro (N/A)
- License Information
